We are live on ! Find out more
MCRB icon

Seres Therapeutics
MCRB

94 hedge funds and large institutions have $382M invested in Seres Therapeutics in 2016 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 39 increasing their positions, 17 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 17

20% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 20

3% more funds holding

Funds holding: 91 → 94 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

58% less capital invested

Capital invested by funds: $916M → $382M (-$534M)

73% less call options, than puts

Call options by funds: $713K | Put options by funds: $2.61M

Holders
94
Holders Change
+3
Holders Change %
+3.3%
% of All Funds
2.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
24
Increased
39
Reduced
17
Closed
20
Calls
$713K
Puts
$2.61M
Net Calls
-$1.9M
Net Calls Change
+$1.58M

Top Buyers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
+$17.3M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$9.05M
3
Deutsche Bank
Deutsche Bank
Germany
+$5.85M
4
Renaissance Technologies
Renaissance Technologies
New York
+$5.2M
5
AG
Artal Group
Luxembourg
+$3.33M

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$19.5M
2
BM
Bridger Management
New York
-$18.1M
3
TCM
TimesSquare Capital Management
New York
-$14.3M
4
CCI
Columbus Circle Investors
-$10.7M
5
CAM
Cormorant Asset Management
Massachusetts
-$7.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
PP
26
PDT Partners
New York
$1.41M +$2.01M +5,730 New
Citadel Advisors
27
Citadel Advisors
Florida
$1.16M +$1.65M +4,707 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$829K +$179K +509 +18%
BIM
29
BlackRock Investment Management
Delaware
$807K -$52.3K -149 -4%
Morgan Stanley
30
Morgan Stanley
New York
$784K +$502K +1,430 +81%
Charles Schwab
31
Charles Schwab
California
$770K +$406K +1,156 +59%
AA
32
ALPS Advisors
Colorado
$631K -$73.3K -209 -8%
American Century Companies
33
American Century Companies
Missouri
$489K -$1.21M -3,454 -63%
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$463K +$5.26K +15 +0.8%
AllianceBernstein
35
AllianceBernstein
Tennessee
$423K -$6.71M -19,117 -92%
Tudor Investment Corp
36
Tudor Investment Corp
Connecticut
$409K +$583K +1,663 New
BIM
37
Bogle Investment Management
Massachusetts
$369K +$528K +1,505 New
TA
38
Teachers Advisors
New York
$352K – – –
ProShare Advisors
39
ProShare Advisors
Maryland
$333K -$78.6K -224 -14%
CS
40
Credit Suisse
Switzerland
$317K +$171K +487 +61%
EEG
41
E.E. Geduld
$307K +$439K +1,250 New
Swiss National Bank
42
Swiss National Bank
Switzerland
$291K – – –
VKH
43
Virtu KCG Holdings
New York
$279K +$399K +1,136 New
HCM
44
Highbridge Capital Management
New York
$275K +$392K +1,118 New
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$262K +$375K +1,068 New
HIM
46
Hillhouse Investment Management
Cayman Islands
$259K +$370K +1,055 New
FRM
47
Fox Run Management
Connecticut
$257K +$367K +1,045 New
Goldman Sachs
48
Goldman Sachs
New York
$244K +$92.3K +263 +36%
BA
49
BlackRock Advisors
Delaware
$236K -$693K -1,974 -67%
TD Asset Management
50
TD Asset Management
Ontario, Canada
$212K -$256K -730 -46%
1
2
3 4 5

MCRB Hedge Fund Activity: Q3 2016 in Review

94 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Seres Therapeutics (MCRB) for Q3 2016, worth a combined $382M — down 58% from $916M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new MCRB positions and 20 closed out — a net gain of 4 holders — while 39 added to existing stakes and 17 trimmed.

The largest buyer was Capital World Investors, adding an estimated $17.3M. The largest seller was Jennison Associates, exiting entirely with an estimated $19.5M sold.

  • 94 institutional investors held Seres Therapeutics (MCRB) as of Q3 2016, up from 91 in Q2 2016.
  • Funds reported $382M of Seres Therapeutics stock for Q3 2016, down 58% quarter-over-quarter.
  • 24 funds opened new Seres Therapeutics positions in Q3 2016 and 20 closed out, a net change of +4 holders.
  • The largest Seres Therapeutics buyer in Q3 2016 was Capital World Investors, an estimated $17.3M added.
  • The largest Seres Therapeutics seller in Q3 2016 was Jennison Associates, an estimated $19.5M sold.

Based on aggregated 13F filings for Q3 2016.